Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...
HPV vaccine can and will prevent cancer, finds study
A University of Otago, Christchurch-led study is heralding the success of the HPV vaccination program, saying the cost and ...
Everyday Health on MSN22h
RFK Jr. Called This Vaccine ‘Dangerous’ — but It's Prevented Thousands of Cancer Cases
A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.
European Medical Journal8h
Personalised Cancer Vaccine Shows Promising Results in High-Risk Kidney Cancer Trial
A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...
Nanoparticle immune therapy shows potential to halt pancreatic cancer spread
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
Healio5h
Cervical precancer incidence falls 80% among women most likely to be vaccinated for HPV
From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting ...
S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism
The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S.
How federally funded research saved my son’s sight — and his life — from a rare cancer
The Trump administration is impeding the National Institutes of Health-backed science that enabled treatment of ...
Trump’s NIH pick grilled on research funding cuts and vaccine views in Senate hearing
President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...
Why Moderna, Inc. (MRNA) Went Up on Wednesday
Moderna, Inc. (NASDAQ:MRNA) shares rose for a second day on Wednesday, adding 15.94 percent to finish at $35.21 apiece as ...
The STI more common in men than women ‘driving rise in dangerous cancers’ – and how to spot if you have it
AN STI that’s more common in men than women is driving a rise in cancers, scientists have warned. The human papillomavirus – known as HPV – is often associated with the risk of ...